BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 164 filers reported holding BLUEBIRD BIO INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,880,000 | -81.9% | 455,000 | +74.5% | 0.36% | -46.0% |
| Q2 2020 | $15,913,000 | -44.4% | 260,700 | -58.1% | 0.67% | -45.4% |
| Q1 2020 | $28,597,000 | -52.1% | 622,210 | -8.6% | 1.22% | -42.6% |
| Q4 2019 | $59,708,000 | +28.2% | 680,430 | +34.2% | 2.13% | +21.0% |
| Q3 2019 | $46,561,000 | -0.6% | 507,090 | +37.8% | 1.76% | -3.1% |
| Q2 2019 | $46,821,000 | -1.7% | 368,090 | +21.5% | 1.82% | -5.6% |
| Q1 2019 | $47,654,000 | – | 302,890 | – | 1.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |